Hering K, Seegelken K
Strahlentherapie. 1976 Jul;152(1):5-8.
90 out of 191 patients with bronchial carcinomas were treated exclusively with telecobalt (focal dose ofer 4,500 rad), 78 patients were given an additional treatment with Proresid, and 23 patients were additionally treated with 5-fluorouracil under so-called synchronization conditions. As far as the Proresid is concerned, the combination with the chemotherapy did not bring about an amelioration of the survival rates compared to the results of the radiotherapy alone. The survival rate of the patients treated with cobalt 60 and with 5-fluorouracil even showed a considerable decrease, so that the described combination therapies are not longer used in our institute.
191例支气管癌患者中，90例仅接受远距钴治疗（局部剂量4500拉德），78例额外接受丙卡巴肼治疗，23例在所谓同步条件下额外接受5-氟尿嘧啶治疗。就丙卡巴肼而言，与单独放疗结果相比，其与化疗联合并未改善生存率。接受钴60和5-氟尿嘧啶治疗的患者生存率甚至显著下降，因此我院不再使用上述联合治疗方法。
